HomeVERA • NASDAQ
add
Vera Therapeutics Inc
Previous close
$41.26
Day range
$39.87 - $43.39
Year range
$18.53 - $49.77
Market cap
2.72B USD
Avg Volume
1.72M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 83.93M | 68.53% |
Net income | -80.29M | -72.18% |
Net profit margin | — | — |
Earnings per share | -1.26 | -48.24% |
EBITDA | -83.80M | -68.36% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 497.39M | 40.78% |
Total assets | 517.50M | 40.41% |
Total liabilities | 118.62M | 49.21% |
Total equity | 398.88M | — |
Shares outstanding | 63.93M | — |
Price to book | 6.61 | — |
Return on assets | -38.29% | — |
Return on capital | -41.07% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -80.29M | -72.18% |
Cash from operations | -61.91M | -67.84% |
Cash from investing | 69.76M | 82.06% |
Cash from financing | 797.00K | 7.85% |
Net change in cash | 8.65M | 298.53% |
Free cash flow | -34.63M | -80.98% |
About
Founded
2016
Headquarters
Website
Employees
224
